Literature DB >> 2745865

Continuous arteriovenous haemofiltration in children.

J Lopez-Herce1, P Dorao, M A Delgado, L Espinosa, F Ruza, M C Martinez.   

Abstract

Continuous arteriovenous haemofiltration (CAVH) was used in 7 critically ill children: a premature neonate with hypervolaemia secondary to hydrops foetalis and six children aged 9 days to 7 years with acute oliguric renal failure. Biospal 0.5 m2, Renaflo 0.25 m2, Gambro 0.15 m2 and Amicon 0.015 m2 filters were used according to the weights and ages of the patients. Adequate removal of water and solutes was obtained in 6 patients. One of the patients with the smallest filter needed a change to a filter with a larger surface area to improve water and solute removal. Haemofiltration was maintained for between 17 hours and 31 days and was well tolerated. CAVH was discontinued because of recovery of renal function in three patients, improvement of the hypervolaemic state in one, death in three, and transfer to continuous ambulatory peritoneal dialysis because of chronic renal failure in one patient. CAVH is a useful technique for the treatment of acute renal failure and hypervolaemia in critically ill children.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745865     DOI: 10.1007/bf00271055

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  14 in total

1.  Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure?

Authors:  R H Bartlett; J R Mault; R E Dechert; J Palmer; R D Swartz; F K Port
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

2.  Arteriovenous haemofiltration in hypervolaemia.

Authors:  G Zobel; M Trop; E Ring; C Suppan; H M Grubbauer
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

3.  Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients.

Authors:  R Raja; M Kramer; S Goldstein; R Caruana; A Lerner
Journal:  ASAIO Trans       Date:  1986 Jul-Sep

4.  Treatment of acute renal failure in an infant using continuous arteriovenous hemofiltration.

Authors:  K V Lieberman; L Nardi; J P Bosch
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

5.  Continuous arteriovenous hemofiltration in critically ill children with acute renal failure.

Authors:  G Zobel; M Trop; E Ring; H M Grubbauer
Journal:  Crit Care Med       Date:  1987-07       Impact factor: 7.598

6.  Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients.

Authors:  M R Leone; R D Jenkins; T A Golper; S R Alexander
Journal:  Crit Care Med       Date:  1986-12       Impact factor: 7.598

7.  Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics.

Authors:  A Lauer; A Saccaggi; C Ronco; M Belledonne; S Glabman; J P Bosch
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

Review 8.  Continuous arteriovenous hemofiltration in children.

Authors:  K V Lieberman
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

9.  Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration.

Authors:  C Ronco; A Brendolan; L Bragantini; S Chiaramonte; M Feriani; A Fabris; R Dell'Aquila; G La Greca
Journal:  Kidney Int       Date:  1986-04       Impact factor: 10.612

10.  Hemofiltration in digoxin overdose.

Authors:  K N Lai; R Swaminathan; C O Pun; J Vallance-Owen
Journal:  Arch Intern Med       Date:  1986-06
View more
  3 in total

1.  Pump-assisted hemofiltration in infants with acute renal failure.

Authors:  E N Ellis; D Pearson; L Robinson; C W Belsha; T G Wells; P L Berry
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

2.  Peritoneal dialysis for acute renal failure in children.

Authors:  V M Reznik; W R Griswold; B M Peterson; A Rodarte; M E Ferris; S A Mendoza
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

3.  Five years experience with continuous extracorporeal renal support in paediatric intensive care.

Authors:  G Zobel; E Ring; M Kuttnig; H M Grubbauer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.